Enable JavaScript to visit this website.

What is XELJANZ?

XELJANZ (tofacitinib) is a prescription medicine called a Janus kinase (JAK) inhibitor used to treat:

  • Adults with moderately to severely active ulcerative colitis when medicines called tumor necrosis factor (TNF) blockers did not work well or cannot be tolerated

It is not known if XELJANZ is safe and effective in children or in people with Hepatitis B or C.

XELJANZ is not recommended for people with severe liver problems.

What do I do if my claim for XELJANZ is denied?

If your request is denied, you may be able to appeal the decision. Call XELSOURCE for help navigating the approval process and to learn more about the support programs that may be available to you.

To speak with a XELSOURCE specialist, call 1-844-935-5269, Monday through Friday, 8:00 am–8:00 pm ET, and say “Representative.”